These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2556223
21. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. O'Carroll AM, Fowler CJ, Phillips JP, Tobbia I, Tipton KF. Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):198-202. PubMed ID: 6408492 [Abstract] [Full Text] [Related]
22. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Guang HM, Du GH. Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097 [Abstract] [Full Text] [Related]
23. Selective influences of age and thyroid hormones on type A monoamine oxidase of the rat heart. Lyles GA, Callingham BA. J Pharm Pharmacol; 1979 Nov; 31(11):755-60. PubMed ID: 41907 [Abstract] [Full Text] [Related]
24. Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity. Grimsby J, Zentner M, Shih JC. Life Sci; 1996 Nov; 58(9):777-87. PubMed ID: 8632725 [Abstract] [Full Text] [Related]
25. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity]. Severina IS, Klimova GI, Nersisian AA. Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482 [Abstract] [Full Text] [Related]
26. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition. Schoepp DD, Azzaro AJ. J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675 [Abstract] [Full Text] [Related]
27. Amylase in thyroid tissues from normal and various thyroid diseases. Biochemical and immunohistochemical study. Mizukami Y, Matsubara F, Hashimoto T, Okumura J, Matsukawa S, Tanishima K. Acta Pathol Jpn; 1987 Feb; 37(2):253-60. PubMed ID: 2440230 [Abstract] [Full Text] [Related]
28. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition. Klegeris A, McGeer PL. Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911 [Abstract] [Full Text] [Related]
29. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. Murphy DL, Lipper S, Slater S, Shiling D. Psychopharmacology (Berl); 1979 Apr 11; 62(2):129-32. PubMed ID: 111275 [Abstract] [Full Text] [Related]
30. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity. Seymour CB, Mothersill C, Mooney R, Moriarty M, Tipton KF. Br J Cancer; 2003 Nov 17; 89(10):1979-86. PubMed ID: 14612913 [Abstract] [Full Text] [Related]
31. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone. Fowler CJ, Benedetti MS. J Neurochem; 1983 Jun 17; 40(6):1534-41. PubMed ID: 6406646 [Abstract] [Full Text] [Related]
32. Multiple forms of monoamine oxidase in developing chick brain. Suzuki O, Katsumata Y, Oya M, Asano M. Dev Neurosci; 1978 Jun 17; 1(3-4):172-6. PubMed ID: 756381 [Abstract] [Full Text] [Related]
33. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. Malin DH, Moon WD, Goyarzu P, Barclay E, Magallanes N, Vela AJ, Negrete AP, Mathews H, Stephens B, Mills WR. Life Sci; 2013 Oct 06; 93(12-14):448-53. PubMed ID: 23988853 [Abstract] [Full Text] [Related]
34. Monoamine oxidase activity in several tissues of the goldfish. Carassius auratus. Hall TR, Urueña G. Comp Biochem Physiol C Comp Pharmacol; 1982 Oct 06; 71(2):145-7. PubMed ID: 6122531 [Abstract] [Full Text] [Related]
35. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y, Mash D, Zhang SH, Stein I. Mol Pharmacol; 1991 Mar 06; 39(3):385-93. PubMed ID: 1848660 [Abstract] [Full Text] [Related]
36. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice. Boden R, Botting R, Coulson P, Spanswick G. Br J Pharmacol; 1984 May 06; 82(1):151-4. PubMed ID: 6428496 [Abstract] [Full Text] [Related]
37. Effect of orthotopic liver transplantation and chemical denervation of the liver on the activities of hepatic monoamine oxidase and catechol-O-methyltransferase. Wheatley AM, McCrodden JM, Stuart ET, Zhao D, Shaw SG, Tipton KF, Blumgart LH. Transplantation; 1993 Jul 06; 56(1):202-7. PubMed ID: 8333043 [Abstract] [Full Text] [Related]
38. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Setini A, Pierucci F, Senatori O, Nicotra A. Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan 06; 140(1):153-61. PubMed ID: 15621520 [Abstract] [Full Text] [Related]
39. Effects of monoamine oxidase inhibitors and dopamine agonists on the behavior of mammal- and frog-eating snakes. Temple JG, Barthalmus GT. Physiol Behav; 1994 May 06; 55(5):927-33. PubMed ID: 7912837 [Abstract] [Full Text] [Related]
40. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. Riederer P, Youdim MB. J Neurochem; 1986 May 06; 46(5):1359-65. PubMed ID: 2420928 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]